Conferences
#ESHAL2022

3rd How to Diagnose and Treat
Acute Leukaemias

‍

#ESHAL2022
Clinical Update
March 10-13, 2022
-
E-Conference

Chairs: Hervé Dombret, Gert Ossenkoppele, Jorge Sierra, Wendy Stock

3rd How to Diagnose and Treat
Acute Leukaemias

‍

Information

‍

ABOUT THE CONFERENCE:

ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management which is greatly facilitated by and discussion of real clinical cases. An important incentive will be to promote interaction between the speakers and participants.

Novel and still evolving insights into the biology and diagnosis of acute leukaemias, including acute myeloid leukaemias (AMLs) and acute lymphoblastic leukaemias (ALL), has resulted in new drug approvals and new therapeutic options to treat newly-diagnosed as well as relapsed/refractory disease.

The programme of this “3rd How to Diagnose and Treat: Acute Leukaemias” meeting will integrate of genomic analysis and cutting-edge technics in routine diagnosis, gene mutation-directed therapies and new standard treatment algorithms, allogeneic haematopoietic stem cell (HSCT) transplantation and innovative immunotherapies, as well as diagnosis and management of rare acute leukaemia subtypes.

‍

SCIENTIFIC TOPICS:

• Diagnosis and rare diseases
• Measurable Residual Disease (MRD)
• Leukaemia treatment dilemmas
• Intensive chemotherapy for older fit patients
• MRD level before transplant
• Leukaemia treatment challenges
• Ph-positive ALL
• CAR-T cell for ALL patients
• Immune therapies to treat leukaemia patients
• Haematopoietic stem cell transplantation

Programme

Read the final programme!

CLICK HERE
ON-DEMAND CONTENT AVAILABLE
CLICK HERE

Corporate partners

With the support of*:

‍

‍Major E-Conference Partner
*******

‍

‍

‍

‍

Level 1 E-Conference Partners
*******

‍

‍

‍‍

Level 2 E-Conference Partner
*******

‍

‍*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

Advancing haematology through international leading-edge disease- focused conferences.

Explore a portfolio of leading-edge scientific, translational research and clinically oriented meetings, designed to foster scientific exchange, practical insight, education and collaboration across clinical and research fields.
Explore all conferences